NRX-100 (preservative-free ketamine) has been granted Fast Track Designation by FDA for treatment of suicidal ideation in ...

A sweeping new study of psychiatric and genetic records has the potential to change treatment for millions of psychiatric ...

NRX-100 (preservative-free ketamine) has been granted Fast Track Designation by FDA for treatment of suicidal ideation in patients with Depression and Bipolar Depression.Real-world evidence, consisten ...

People with mental illness have a higher risk of developing diabetes due to multiple factors. However, they do not receive ...

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

Researchers from across China have discovered that schizophrenia (SCZ), bipolar disorder (BD) and major depressive disorder, ...

Use of private providers, poor training and inadequate regulation mean obtaining care has become a ‘wild west’ ...

Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.

Key market opportunities in the Bipolar Disorder market include developing targeted treatments for bipolar depression due to current unmet needs, capitalizing on late-stage pipeline products projected ...

BioXcel Therapeutics Inc. has named longtime biopharmaceutical executive Mark Pavao as its acting chief commercial officer, ...

Arguably, the most important thing you can have in this life is your health. No matter how much money you have or resources ...

Licenses Real-World Evidence From 70,000 Patients To Support FDA Accelerated Approval Of NRX-100. NRx Pharmaceuticals (NASDAQ: NRXP) announced it has licensed regulatory-grade real-world evidence ...